Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern

被引：0
|
作者：
Monika Kumari
Shih-Chieh Su
Kang-Hao Liang
Hsiu-Ting Lin
Yu-Feng Lu
Kai-Chi Chen
Wan-Yu Chen
Han-Chung Wu
机构：
[1] Academia Sinica,Institute of Cellular and Organismic Biology
[2] Academia Sinica,Biomedical Translation Research Center (BioTReC)
来源：
Journal of Biomedical Science | / 30卷
关键词：
SARS-CoV-2; Variants of concern (VOCs); Bivalent mRNA vaccines; Vaccine efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Evaluation of vaccine effectiveness against SARS-CoV-2 variants by serological epitope profiling
    Li, Cheng
    Yang, Zhenlin
    Wu, Yanling
    Ying, Tianlei
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (01):
  • [22] A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections
    Wu, Namei
    Zhang, Jiachen
    Shen, Yanqiong
    Zhang, Xinghai
    Zhou, Jinge
    Wu, Yan
    Li, Entao
    Meng, Xiaoming
    Chuai, Xia
    Chiu, Sandra
    Wang, Yucai
    MOLECULAR THERAPY, 2024, 32 (04) : 1033 - 1047
  • [23] A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
    Yuan, Yaochang
    Zhang, Xiantao
    Chen, Ran
    Li, Yuzhuang
    Wu, Bolin
    Li, Rong
    Zou, Fan
    Ma, Xiancai
    Wang, Xuemei
    Chen, Qier
    Deng, Jieyi
    Zhang, Yongli
    Chen, Tao
    Lin, Yingtong
    Yan, Shumei
    Zhang, Xu
    Li, Congrong
    Bu, Xiuqing
    Peng, Yi
    Ke, Changwen
    Deng, Kai
    Pan, Ting
    He, Xin
    Zhang, Yiwen
    Zhang, Hui
    CELL REPORTS, 2022, 38 (03):
  • [24] A bivalent subunit vaccine efficiently produced in Pichia pastoris against SARS-CoV-2 and emerging variants
    Xu, Huifang
    Wang, Tiantian
    Sun, Peng
    Hou, Xuchen
    Gong, Xin
    Zhang, Bin
    Wu, Jun
    Liu, Bo
    FRONTIERS IN MICROBIOLOGY, 2023, 13
  • [25] Are the new SARS-CoV-2 variants resistant against the vaccine?
    Abdalla, Mohnad
    El-Arabey, Amr Ahmed
    Jiang, Xinyi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (10) : 3489 - 3490
  • [26] Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
    Yoon, Sarang K.
    Hegmann, Kurt T.
    Thiese, Matthew S.
    Burgess, Jefferey L.
    Ellingson, Katherine
    Lutrick, Karen
    Olsho, Lauren E. W.
    Edwards, Laura J.
    Sokol, Brian
    Caban-Martinez, Alberto J.
    Schaefer-Solle, Natasha
    Jones, John M.
    Tyner, Harmony
    Hunt, Angela
    Respet, Karley
    Gaglani, Manjusha
    Dunnigan, Kayan
    Rose, Spencer
    Naleway, Allison
    Groom, Holly
    Kuntz, Jennifer
    Fowlkes, Ashley L.
    Thompson, Mark G.
    Yoo, Young M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (19): : 1855 - 1857
  • [27] Circular mRNA Vaccine against SARS-COV-2 Variants Enabled by Degradable Lipid Nanoparticles
    Department of Chemical and Biological Engineering, Monash University, Clayton
    VIC
    3800, Australia
    不详
    215125, China
    不详
    410208, China
    不详
    215123, China
    ACS Appl. Mater. Interfaces, 2025, 17 (03): : 4699 - 4710
  • [28] mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern
    Wang, Haomeng
    Chen, Zhao
    Wang, Zhenghua
    Li, Jin
    Yan, Zhihong
    Yuan, Jinbo
    Zhu, Airu
    Chen, Lan
    Liu, Ye
    Hu, Chenlong
    Zhu, Ali
    Li, Guowei
    Li, Yuehu
    Deng, Jie
    Ma, Liqiao
    Sui, Xiuwen
    Miao, Wei
    Li, Junqiang
    Zheng, Xiuyu
    Piao, Jinhua
    Yao, Yanfeng
    Rao, Juhong
    Shan, Chao
    Yuan, Zhiming
    Zhao, Jincun
    Zhu, Tao
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 1550 - 1553
  • [29] The emerging SARS-CoV-2 variants of concern
    Sanyaolu, Adekunle
    Okorie, Chuku
    Marinkovic, Aleksandra
    Haider, Nafees
    Abbasi, Abu Fahad
    Jaferi, Urooj
    Prakash, Stephanie
    Balendra, Vyshnavy
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [30] SARS-CoV-2 variants of concern: a review
    Sarkar, Malay
    Madabhavi, Irappa
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
12345